0001743745false2022Q112-310.3333P3Y0.333300017437452022-01-012022-03-310001743745us-gaap:CommonClassAMember2022-05-12xbrli:shares0001743745us-gaap:CommonClassBMember2022-05-1200017437452022-03-31iso4217:USD00017437452021-12-310001743745us-gaap:NotesPayableOtherPayablesMember2021-12-310001743745us-gaap:NotesPayableOtherPayablesMember2022-03-31iso4217:USDxbrli:shares0001743745us-gaap:CommonClassAMember2022-03-310001743745us-gaap:CommonClassAMember2021-12-310001743745us-gaap:CommonClassBMember2021-12-310001743745us-gaap:CommonClassBMember2022-03-310001743745us-gaap:CommonClassCMember2022-03-310001743745us-gaap:CommonClassCMember2021-12-3100017437452021-01-012021-03-310001743745us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-12-310001743745us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-12-310001743745us-gaap:CommonClassCMemberus-gaap:CommonStockMember2021-12-310001743745us-gaap:AdditionalPaidInCapitalMember2021-12-310001743745us-gaap:RetainedEarningsMember2021-12-310001743745us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001743745us-gaap:NoncontrollingInterestMember2021-12-310001743745us-gaap:RetainedEarningsMember2022-01-012022-03-310001743745us-gaap:NoncontrollingInterestMember2022-01-012022-03-310001743745us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-01-012022-03-310001743745us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001743745us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-01-012022-03-310001743745us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001743745us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-03-310001743745us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-03-310001743745us-gaap:CommonClassCMemberus-gaap:CommonStockMember2022-03-310001743745us-gaap:AdditionalPaidInCapitalMember2022-03-310001743745us-gaap:RetainedEarningsMember2022-03-310001743745us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001743745us-gaap:NoncontrollingInterestMember2022-03-310001743745us-gaap:CommonClassAMemberus-gaap:CommonStockMember2020-12-310001743745us-gaap:CommonStockMemberus-gaap:CommonClassBMember2020-12-310001743745us-gaap:CommonClassCMemberus-gaap:CommonStockMember2020-12-310001743745us-gaap:AdditionalPaidInCapitalMember2020-12-310001743745us-gaap:RetainedEarningsMember2020-12-310001743745us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001743745us-gaap:NoncontrollingInterestMember2020-12-3100017437452020-12-310001743745us-gaap:RetainedEarningsMember2021-01-012021-03-310001743745us-gaap:NoncontrollingInterestMember2021-01-012021-03-310001743745us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-01-012021-03-310001743745us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001743745us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001743745us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-01-012021-03-310001743745us-gaap:CommonClassCMemberus-gaap:CommonStockMember2021-01-012021-03-310001743745us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-03-310001743745us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-03-310001743745us-gaap:CommonClassCMemberus-gaap:CommonStockMember2021-03-310001743745us-gaap:AdditionalPaidInCapitalMember2021-03-310001743745us-gaap:RetainedEarningsMember2021-03-310001743745us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001743745us-gaap:NoncontrollingInterestMember2021-03-3100017437452021-03-310001743745gnln:KushCoMembergnln:FormerGreenlaneStockholdersMember2021-08-31xbrli:pure0001743745gnln:FormerKushCoStockholdersMembergnln:KushCoMember2021-08-310001743745us-gaap:CommonClassBMember2021-08-310001743745us-gaap:CommonClassAMember2021-08-31gnln:retailLocation0001743745us-gaap:CommonClassAMember2022-01-012022-03-310001743745us-gaap:CommonClassBMember2022-01-012022-03-31gnln:vote0001743745us-gaap:CommonClassBMember2021-08-312021-08-310001743745gnln:ATMProgramMemberus-gaap:CommonClassAMember2021-08-012021-08-310001743745gnln:ATMProgramMemberus-gaap:CommonClassAMember2021-08-012022-03-310001743745gnln:ATMProgramMember2021-08-012022-03-310001743745srt:ScenarioPreviouslyReportedMember2021-01-012021-03-310001743745srt:RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember2021-01-012021-03-31gnln:segment0001743745gnln:BillAndHoldMember2022-01-012022-03-310001743745gnln:BillAndHoldMember2021-01-012021-03-310001743745us-gaap:IPOMembergnln:AirgraftIncMember2022-03-310001743745us-gaap:IPOMembergnln:AirgraftIncMember2021-12-310001743745us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembergnln:Customer1Member2022-01-012022-03-310001743745us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembergnln:Customer1Member2022-01-012022-03-310001743745gnln:Customer2Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2022-01-012022-03-310001743745us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembergnln:Customer3Member2022-01-012022-03-310001743745us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembergnln:Customer1Member2021-01-012021-12-310001743745gnln:Customer2Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2021-01-012021-12-310001743745gnln:EyceDaVinciAndKushCoMember2022-01-012022-03-310001743745gnln:EyceDaVinciAndKushCoMember2021-01-012021-03-310001743745us-gaap:FairValueInputsLevel1Member2022-03-310001743745us-gaap:FairValueInputsLevel2Member2022-03-310001743745us-gaap:FairValueInputsLevel3Member2022-03-310001743745us-gaap:FairValueInputsLevel1Member2021-12-310001743745us-gaap:FairValueInputsLevel2Member2021-12-310001743745us-gaap:FairValueInputsLevel3Member2021-12-310001743745us-gaap:InterestRateSwapMember2022-03-310001743745gnln:ContingentConsiderationMember2021-12-310001743745gnln:ContingentConsiderationMembergnln:EyceLLCMember2022-01-012022-03-310001743745gnln:ContingentConsiderationMembergnln:OrganicixLLCMember2022-01-012022-03-310001743745gnln:ContingentConsiderationMember2022-01-012022-03-310001743745gnln:ContingentConsiderationMember2022-03-310001743745gnln:ContingentConsiderationMember2020-12-310001743745gnln:ContingentConsiderationMembergnln:EyceLLCMember2021-01-012021-03-310001743745gnln:ContingentConsiderationMember2021-03-3100017437452019-01-012019-12-310001743745srt:MinimumMember2022-03-310001743745srt:MaximumMember2022-03-31gnln:lease0001743745us-gaap:RealEstateLoanMember2022-03-310001743745us-gaap:RealEstateLoanMember2021-12-310001743745gnln:OrganicixLLCMemberus-gaap:NotesPayableOtherPayablesMember2022-03-310001743745gnln:OrganicixLLCMemberus-gaap:NotesPayableOtherPayablesMember2021-12-310001743745us-gaap:NotesPayableOtherPayablesMembergnln:EyceLLCMember2022-03-310001743745us-gaap:NotesPayableOtherPayablesMembergnln:EyceLLCMember2021-12-310001743745us-gaap:RealEstateLoanMember2018-10-010001743745us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RealEstateLoanMember2018-10-012018-10-010001743745us-gaap:UnsecuredDebtMembergnln:EyceLLCMember2021-03-310001743745us-gaap:UnsecuredDebtMembergnln:OrganicixLLCMember2021-11-300001743745us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001743745us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-12-310001743745us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-03-310001743745us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-01-012022-03-310001743745us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310001743745us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-03-310001743745us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001743745us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-12-310001743745us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-03-310001743745us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-012021-03-310001743745us-gaap:AccumulatedTranslationAdjustmentMember2021-03-310001743745us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-03-310001743745gnln:FourMajorVendorsMemberus-gaap:SalesRevenueNetMemberus-gaap:SupplierConcentrationRiskMember2022-01-012022-03-310001743745gnln:FourMajorVendorsMemberus-gaap:SalesRevenueNetMemberus-gaap:SupplierConcentrationRiskMember2021-01-012021-03-310001743745gnln:FourMajorVendorsMembergnln:PurchasesBenchmarkMemberus-gaap:SupplierConcentrationRiskMember2022-01-012022-03-310001743745gnln:FourMajorVendorsMembergnln:PurchasesBenchmarkMemberus-gaap:SupplierConcentrationRiskMember2021-01-012021-03-310001743745gnln:UnrivaledBrandsIncMember2022-01-012022-03-310001743745gnln:UnrivaledBrandsIncMember2021-01-012021-03-310001743745gnln:UnrivaledBrandsIncMember2022-03-310001743745gnln:UnrivaledBrandsIncMember2021-12-310001743745gnln:UniversalGrowingMember2021-01-012021-03-310001743745gnln:UniversalGrowingMember2022-01-012022-03-3100017437452019-11-300001743745gnln:GreenlaneHoldingsLLCMember2022-03-310001743745gnln:ATMProgramMemberus-gaap:SubsequentEventMember2022-04-180001743745gnln:ATMProgramMemberus-gaap:CommonClassAMember2022-01-012022-03-310001743745gnln:ATMProgramMember2022-01-012022-03-310001743745us-gaap:CommonClassAMember2021-08-092021-08-090001743745gnln:PreFundedWarrantsMember2021-08-090001743745gnln:StandardWarrantsMember2021-08-0900017437452021-08-0900017437452021-08-092021-08-090001743745us-gaap:WarrantMemberus-gaap:CommonClassAMember2022-01-012022-03-310001743745us-gaap:CommonClassCMember2021-08-310001743745gnln:KushCoMemberus-gaap:CommonClassBMember2021-08-312021-08-310001743745gnln:TwoThousandNineteenEquityIncentivePlanMember2021-07-310001743745gnln:TwoThousandNineteenEquityIncentivePlanMember2021-08-012021-08-310001743745us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001743745us-gaap:EmployeeStockOptionMember2021-01-012021-03-310001743745us-gaap:RestrictedStockMember2022-01-012022-03-310001743745us-gaap:RestrictedStockMember2021-01-012021-03-310001743745us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001743745us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-03-310001743745us-gaap:CommonStockMember2022-01-012022-03-310001743745us-gaap:CommonStockMember2021-01-012021-03-310001743745us-gaap:EmployeeStockOptionMember2022-03-310001743745us-gaap:RestrictedStockMember2022-03-310001743745us-gaap:RestrictedStockUnitsRSUMember2022-03-3100017437452021-01-012021-12-310001743745gnln:ConsumerGoodsMember2022-01-012022-03-310001743745gnln:IndustrialGoodsMember2022-01-012022-03-310001743745gnln:ConsumerGoodsMember2021-01-012021-03-310001743745gnln:IndustrialGoodsMember2021-01-012021-03-310001743745gnln:ConsumerGoodsMember2022-03-310001743745gnln:IndustrialGoodsMember2022-03-310001743745gnln:ConsumerGoodsMember2021-12-310001743745gnln:IndustrialGoodsMember2021-12-310001743745gnln:EyceLLCMemberus-gaap:SubsequentEventMember2022-04-07gnln:tranche










UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2022
OR
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from          to         
001-38875
(Commission file number)
Greenlane Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware83-0806637
State or other jurisdiction of
incorporation or organization
(I.R.S. Employer
Identification No.)
1095 Broken Sound Parkway,Suite 300
Boca Raton, FL33487
(Address of principal executive offices)(Zip Code)
(877) 292-7660
Registrant’s telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A Common Stock, $0.01 par value per shareGNLNNasdaq Global Market
Securities registered pursuant to Section 12 (g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes     No 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15 (d) of the Act. Yes     No 
Indicate by check mark whether the registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes     No  £
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes   No 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
£
Accelerated filer
£
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.












Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes     No  ☒
As of May 12, 2022, Greenlane Holdings, Inc. had 106,882,892 shares of Class A common stock outstanding and 21,184,919 shares of Class B common stock outstanding.





Greenlane Holdings, Inc.
Form 10-Q
For the Quarterly Period Ended March 31, 2022

TABLE OF CONTENTS
Page
Item 1.
Item 2.
Item 3.
Item 4.
Other Information
Item 1.
Item 1A.
Item 2.
Item 5.
Item 6.
Signatures




PART I
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

GREENLANE HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except par value per share amounts)
March 31,
2022
December 31,
2021
ASSETS(Unaudited)
Current assets
Cash$5,944 $12,857 
Accounts receivable, net of allowance of $1,409 and $1,285 at March 31, 2022 and December 31, 2021, respectively
19,903 14,690 
Inventories, net68,526 66,982 
Vendor deposits12,485 18,475 
Other current assets (Note 8)11,959 11,733 
Total current assets118,817 124,737 
Property and equipment, net22,356 20,851 
Intangible assets, net83,235 84,710 
Goodwill41,819 41,860 
Operating lease right-of-use assets7,042 9,128 
Other assets7,855 4,541 
Total assets$281,124 $285,827 
LIABILITIES
Current liabilities
Accounts payable$30,535 $23,041 
Accrued expenses and other current liabilities (Note 8)25,271 25,297 
Customer deposits6,838 7,924 
Current portion of notes payable, including $8,000 owed to related party
11,602 11,615 
Current portion of operating leases2,828 3,091 
Total current liabilities77,074 70,968 
Notes payable, less current portion and debt issuance costs, net9,633 10,607 
Operating leases, less current portion4,346 6,142 
Other liabilities821 1,746 
Total long-term liabilities14,800 18,495 
Total liabilities91,874 89,463 
Commitments and contingencies (Note 7)
STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value, 10,000 shares authorized, none issued and outstanding
  
Class A common stock, $0.01 par value per share, 600,000 shares authorized; 102,600 shares issued and outstanding as of March 31, 2022; 85,210 shares issued and outstanding as of December 31, 2021
1,026 852 
Class B common stock, $0.0001 par value per share, 30,000 shares authorized; 21,185 shares issued and outstanding as of March 31, 2022; 21,745 shares issued and outstanding as of December 31, 2021
2 2 
Class C Common stock, $0.0001 par value per share, no shares authorized, issued and outstanding as of March 31, 2022 and December 31, 2021
  
Additional paid-in capital240,280 228,894 
Accumulated deficit(70,876)(55,544)
Accumulated other comprehensive income (loss)685 324 
Total stockholders’ equity attributable to Greenlane Holdings, Inc.
171,117 174,528 
Non-controlling interest18,133 21,836 
Total stockholders’ equity189,250 196,364 
Total liabilities and stockholders’ equity$281,124 $285,827 





GREENLANE HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Unaudited)
(in thousands, except per share amounts)
Three months ended March 31,
20222021
Net sales$46,534 $34,009 
Cost of sales40,566 25,454 
Gross profit5,968 8,555 
Operating expenses:
Salaries, benefits and payroll taxes10,061 6,370 
General and administrative11,715 9,581 
Depreciation and amortization2,403 544 
Total operating expenses24,179 16,495 
Loss from operations(18,211)(7,940)
Other income (expense), net:
Interest expense(406)(116)
Other income (expense), net(54)324 
Total other income (expense), net(460)208 
Loss before income taxes(18,671)(7,732)
Provision for (benefit from) income taxes78 (18)
Net loss(18,749)(7,714)
Less: Net loss attributable to non-controlling
interest
(3,417)(3,458)
Net loss attributable to Greenlane Holdings, Inc.$(15,332)$(4,256)
Net loss attributable to Class A common stock per share - basic and diluted (Note 9)
$(0.17)$(0.28)
Weighted-average shares of Class A common stock outstanding - basic and diluted (Note 9)
90,170 15,263 
Other comprehensive income (loss):
Foreign currency translation adjustments88 (155)
Unrealized gain (loss) on derivative instrument358 204 
Comprehensive loss
(18,303)(7,665)
Less: Comprehensive loss attributable to non-controlling interest
(3,331)(3,427)
Comprehensive loss attributable to Greenlane Holdings, Inc.
$(14,972)$(4,238)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5


GREENLANE HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited)
(in thousands)

Class A
Common Stock
Class B
Common Stock
Class C
Common Stock
Additional
Paid-In
Capital
Accumulated
Deficit
Accumulated
Other
Comprehensive
Income (Loss)
Non-
Controlling
Interest
Total
Stockholders’
Equity
SharesAmountSharesAmountSharesAmount
Balance December 31, 202185,210 $852 21,745 $2  $ $228,894 $(55,544)$324 $21,836 $196,364 
Net loss— — — — — — — (15,332)— (3,417)(18,749)
Equity-based compensation1,870 19 — — — — 711 — — 172 902 
Issuance of Class A shares, net of costs - ATM Program11,135 111 — — — — 6,690 — — — 6,801 
Issuance of Class A shares - contingent consideration3,826 38 — — — — 3,448 — — — 3,486 
Exchanges of noncontrolling interest for Class A common stock560 6 (560)— — — 537 — — (543) 
Other comprehensive income— — — — — — — — 361 85 446 
Balance March 31, 2022102,601 $1,026 21,185 $2  $ $240,280 $(70,876)$685 $18,133 $189,250 
Class A
Common Stock
Class B
Common Stock
Class C
Common Stock
Additional
Paid-In
Capital
Accumulated
Deficit
Accumulated
Other
Comprehensive
Income (Loss)
Non-
Controlling
Interest
Total
Stockholders’
Equity
SharesAmountSharesAmountSharesAmount
Balance December 31, 202013,322 $133 3,491 $1 76,039 $8 $39,742 $(24,848)$29 $54,192 $69,257 
Net loss— — — — — — — (4,256)— (3,458)(7,714)
Equity-based compensation226 2 — — — — 180 — — 324 506 
Other comprehensive income— — — — — — — — 18 31 49 
Issuance of Class A common stock426 4 — — — — 2,001 — — — 2,005 
Exchanges of noncontrolling interest for Class A common stock2,368 24 (1,043)— (3,975)(1)5,774 — — (5,797) 
Cancellation of Class B common stock due to forfeitures— — (5)— — — 8 — — (8) 
Balance March 31, 202116,342 $163 2,443 $1 72,064 $7 $47,705 $(29,104)$47 $45,284 $64,103 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
6


GREENLANE HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(in thousands)
Three months ended March 31,
20222021
Cash flows from operating activities:
Net loss (including amounts attributable to non-controlling interest)$(18,749)$(7,714)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization2,403 544 
Equity-based compensation expense874 529 
Change in provision for doubtful accounts227 101 
Gain related to indemnification asset(1,798)(621)
Unrealized loss on equity investments302  
Other(183)5 
Changes in operating assets and liabilities, net of the effects of acquisitions:
Decrease (increase) in accounts receivable(5,440)713 
Decrease (increase) in inventories(1,545)1,462 
Decrease (increase) in vendor deposits5,990 433 
Decrease (increase) in other current assets(3,624)1,147 
(Decrease) increase in accounts payable5,859 (10,450)
(Decrease) Increase in accrued expenses and other liabilities4,748 (1,943)
(Decrease) increase in customer deposits(1,087)537 
Net cash used in operating activities(12,023)(15,257)
Cash flows from investing activities:
Purchase consideration paid for acquisitions, net of cash acquired (2,403)
Purchases of property and equipment, net(784)(419)
Proceeds from sale of assets held for sale75  
Net cash used in investing activities(709)(2,822)
Cash flows from financing activities:
Proceeds from issuance of Class A common stock, net of costs - ATM Program6,801  
Payments on notes payable(992)(47)
Other(135)(57)
Net cash provided by (used in) financing activities5,674 (104)
Effects of exchange rate changes on cash145 57 
Net (decrease) in cash(6,913)(18,126)
Cash, as of beginning of the period12,857 30,435 
Cash, as of end of the period$5,944 $12,309 
Supplemental disclosures of cash flow information
Cash paid for amounts included in the measurement of lease liabilities$802 $373 
Lease liabilities arising from obtaining finance lease assets$ $119 
Lease liabilities arising from obtaining operating lease right-of-use assets, net of the effect of acquisitions$ $793 
Non-cash investing and financing activities:
Issuance of Class A common stock for business acquisitions$3,486 $1,218 
Non-cash purchases of property and equipment$1,663 $287 
Issuance of promissory note for business acquisition$ $2,503 
Decrease in non-controlling interest as a result of exchanges for Class A common stock$(543)$(5,797)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
7


GREENLANE HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1. BUSINESS OPERATIONS AND ORGANIZATION
Organization
Greenlane Holdings, Inc. (“Greenlane” and, collectively with the Operating Company (as defined below) and its consolidated subsidiaries, the “Company”, "we", "us", and "our") was formed as a Delaware corporation on May 2, 2018. We are a holding company that was formed for the purpose of completing an underwritten initial public offering (“IPO”) of shares of our Class A common stock, $0.01 par value per share (“Class A common stock”), in order to carry on the business of Greenlane Holdings, LLC (the “Operating Company”). The Operating Company was organized under the laws of the state of Delaware on September 1, 2015, and is based in Boca Raton, Florida. Unless the context otherwise requires, references to the “Company” refer to us, and our consolidated subsidiaries, including the Operating Company.
We are the sole manager of the Operating Company and our principal asset is Common Units of the Operating Company (“Common Units”). As the sole manager of the Operating Company, we operate and control all of the business and affairs of the Operating Company, and we conduct our business through the Operating Company and its subsidiaries. We have a board of directors and executive officers, but no employees. All of our assets are held and all of the employees are employed by the Operating Company and its subsidiaries.
We have the sole voting interest in, and control the management of, the Operating Company, and we have the obligation to absorb losses of, and receive benefits from, the Operating Company, that could be significant. We determined that the Operating Company is a variable interest entity (“VIE”) and that we are the primary beneficiary of the Operating Company. Accordingly, pursuant to the VIE accounting model, beginning in the fiscal quarter ended June 30, 2019, we consolidated the Operating Company in our consolidated financial statements and reported a non-controlling interest related to the Common Units held by the members of the Operating Company (other than the Common Units held by us) on our consolidated financial statements.
On August 31, 2021, we completed our previously announced merger with KushCo Holdings, Inc. ("KushCo") and have included the results of operations of KushCo in our consolidated statements of operations and comprehensive loss from that date forward. As such, KushCo financial information is included in our condensed consolidated financial statements for the three months ended March 31, 2022, and is excluded from the comparative period in 2021. Immediately following the merger with KushCo, stockholders that held Class A common stock prior to the completion of the merger owned 51.9% and former KushCo stockholders owned 48.1% of the equity of the combined company on a fully diluted basis. In connection with the merger with KushCo, the Greenlane Certificate of Incorporation was amended and restated (the “A&R Charter”) in order to (i) increase the number of authorized shares of Greenlane Class B common stock, $0.0001 par value per share (the “Class B Common stock”), from 10 million shares to 30 million shares in order to effect the conversion of each outstanding share of Class C common stock, $0.0001 par value per share (the “Class C common stock”), into one-third of one share of Class B common stock, (ii) increase the number of authorized shares of Class A common stock from 125 million shares to 600 million shares, and (iii) eliminate references to the Class C common stock. Pursuant to the terms of an Agreement and Plan of Merger, dated as of March 31, 2021 (the "Merger Agreement") with KushCo, immediately prior to the consummation of the business combination, holders of Class C common stock received one-third of one share of Class B common stock for each share of Class C common stock held immediately prior to the closing of the merger.
We merchandise premium cannabis accessories, child-resistant packaging, specialty vaporization solutions and lifestyle products in the United States, Canada and Europe, serving a diverse and expansive customer base with more than 8,500 retail locations, including licensed cannabis dispensaries, smoke shops, and specialty retailers. We distribute to multi-state operators ("MSOs"), licensed producers ("LPs"), other retailers and brands through wholesale operations under our Industrial Goods business segment, and to consumers through both wholesale operations as well as e-commerce activities and our retail stores under our Consumer Goods business segment.
Our corporate structure is commonly referred to as an “Up-C” structure. The Up-C structure allows the members of the Operating Company to continue to realize tax benefits associated with owning interests in an entity that is treated as a partnership, or “pass-through” entity. One of these benefits is that future taxable income of the Operating Company that is allocated to its members will be taxed on a flow-through basis and therefore will not be subject to corporate taxes at the Operating Company entity level. Additionally, because the members may redeem their Common Units for shares of Class A common stock on a one-for-one basis or, at our option, for cash, the Up-C structure also provides the members with potential liquidity that holders of non-publicly traded limited liability companies are not typically afforded.
In connection with our initial public offering, we entered into a Tax Receivable Agreement (the “TRA”) with the Operating Company and the Operating Company’s members (other than Greenlane Holdings, Inc.) and a Registration Rights (the “Registration Rights Agreement”) with the Operating Company’s members. The TRA provides for the payment by us to the Operating Company’s members of 85.0% of the amount of tax benefits, if any, that we may actually realize (or in some cases,
8


are deemed to realize) as a result of (i) the step-up in tax basis in our share of the Operating Company's assets resulting from the redemption of Common Units under the mechanism described above and (ii) certain other tax benefits attributable to payments made under the TRA. Pursuant to the Registration Rights Agreement, we have agreed to register the resale of shares of Class A common stock that are issuable to the Operating Company’s members upon redemption or exchange of their Common Units.

The A&R Charter and the Fourth Amended and Restated Operating Agreement of the Operating Company (the “Operating Agreement”) require that (a) we at all times maintain a ratio of one Common Unit owned by us for each share of our Class A common stock issued by us (subject to certain exceptions), and (b) the Operating Company at all times maintains (i) a one-to-one ratio between the number of shares of our Class A common stock issued by us and the number of Common Units owned by us, and (ii) a one-to-one ratio between the number of shares of our Class B common stock owned by the non-founder members of the Operating Company and the number of Common Units owned by the non-founder members of the Operating Company.
The following table sets forth the economic and voting interests of our common stock holders as of March 31, 2022:
Class of Common Stock (ownership)
Total Shares (1)
Class A Shares (as converted) (2)
Economic Ownership in the Operating Company (3)
Voting Interest in Greenlane (4)
Economic Interest in Greenlane (5)
Class A102,599,528 102,599,528 82.9 %82.9 %100.0 %
Class B21,184,919 21,184,919 17.1 %17.1 % %
Total123,784,447 123,784,447 100.0 %100.0 %100.0 %
(1) Represents the total number of outstanding shares for each class of common stock as of March 31, 2022.
(2) Represents the number of shares of Class A common stock that would be outstanding assuming the exchange of all outstanding shares of Class B common stock upon redemption of all related Common Units. Shares of Class B common stock would be canceled, without consideration, on a one-to-one basis pursuant to the terms and subject to the conditions of the Operating Agreement.
(3) Represents the indirect economic interest in the Operating Company through the holders' ownership of common stock.
(4) Represents the aggregate voting interest in us through the holders' ownership of Common Stock. Each share of Class A common stock and Class B common stock entitles its holder to one vote per share on all matters submitted to a vote of our stockholders.
(5) Represents the aggregate economic interest in us through the holders' ownership of Class A common stock.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
Our unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2021. The condensed consolidated results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022, or any other future annual or interim period. Certain reclassifications have been made to prior year amounts or balances to conform to the presentation adopted in the current year.
Principles of Consolidation
Our condensed consolidated financial statements include our accounts, the accounts of the Operating Company, and the accounts of the Operating Company's consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Liquidity
Our principal sources of liquidity at March 31, 2022 consisted of cash on hand, future cash anticipated to be generated from operations, and our ATM Program described below.

We have an effective shelf registration statement on Form S-3 (the "Shelf Registration Statement") and may opportunistically conduct securities offerings from time to time in order to meet our liquidity needs. However, we may be unable to access the capital markets because of current market volatility and the performance of our stock price.
9


In August 2021, we established an "at-the-market" equity offering program (the "ATM Program") that provides for the sale of shares of our Class A common stock having an aggregate offering price of up to $50 million, from time to time, through Cowen and Company, LLC ("Cowen"), as the sales agent. Net proceeds from sales of our shares of Class A common stock under the ATM Program are expected to be used for working capital and general corporate purposes. Since the launch of the ATM program in August 2021 and through March 31, 2022, we sold 13,535,970 shares of our Class A common stock under the ATM Program, which generated gross proceeds of approximately $10.4 million and paid fees to the sales agent of approximately $0.3 million. In connection with the filing of our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “2021 Annual Report”) with the SEC on March 31, 2022, the ATM Program became subject to the offering limits set forth in General Instruction I.B.6 of Form S-3 ("Instruction I.B.6") because our public float was less than $75 million. The ATM Program was subsequently amended on April 18, 2022 to reflect the Instruction I.B.6 limitations. For so long as our public float is less than $75 million, the aggregate market value of the shares of Class A common stock sold by us pursuant to Instruction I.B.6 during any twelve consecutive months may not exceed one-third of our public float.

In December 2021, we entered into the Bridge Loan with Aaron LoCascio, our co-founder, former Chief Executive Officer and President, and a current director of the Company, in which Mr. LoCascio provided us with a loan in the principal amount of $8.0 million. Accrued interest at a rate of 15.0% is due monthly, and principal amount is due in full in June 2022. The Bridge Loan is secured by a continuing security interest in all of our assets and properties whether then or thereafter existing or required, including our inventory and receivables (as defined under the Universal Commercial Code) and includes negative covenants restricting our ability to incur further indebtedness and engage in certain asset dispositions until the earlier of June 30, 2022 or the Bridge Loan has been fully repaid.

We are in the process of securing an asset backed loan to assist us with working capital needs. However, we can provide no assurances as to the timing of our entry into this loan or that we will enter into it at all. We believe that our cash on hand, combined with our ability to access the capital markets, will be sufficient to fund our working capital and capital expenditure requirements, as well as our debt repayments and other liquidity requirements associated with our existing operations, for at least the next 12 months.
Use of Estimates
Conformity with U.S. GAAP requires the use of estimates and judgments that affect the reported amounts in our condensed consolidated financial statements and accompanying notes. These estimates form the basis for judgments we make about the carrying values of our assets and liabilities, which are not readily apparent from other sources. We base our estimates and judgments on historical information and on various other assumptions that we believe are reasonable under the circumstances. U.S. GAAP requires us to make estimates and judgments in several areas. Such areas include, but are not limited to: the collectability of accounts receivable; the allowance for slow-moving or obsolete inventory; the realizability of deferred tax assets; the fair value of goodwill; the fair value of contingent consideration arrangements; the useful lives of intangible assets and property and equipment; the calculation of our VAT taxes receivable and VAT taxes, fines, and penalties payable; our loss contingencies, including our TRA liability; and the valuation and assumptions underlying equity-based compensation. These estimates are based on management's knowledge about current events and expectations about actions we may undertake in the future. Actual results could differ materially from those estimates.
In March 2020, the World Health Organization declared the novel coronavirus ("COVID-19") a global pandemic. We expect uncertainties around our key accounting estimates to continue to evolve depending on the duration and degree of impact associated with the COVID-19 pandemic, including the possible resurgence of new strains. Our estimates may change as new events occur and additional information emerges, and such changes are recognized or disclosed in our condensed consolidated financial statements.
Voluntary Change in Accounting Principle
During the first quarter of 2022, we made a voluntary change in accounting principle to classify outbound shipping and handling costs associated with the distribution of products to our customers as a component of "general and administrative" costs within our condensed consolidated statements of operations and comprehensive loss. These costs were previously recorded as a component of "cost of sales" within our condensed consolidated statements of operations and comprehensive loss. We made the voluntary change in accounting principle because we believe the classification of outbound shipping and handling costs within "general and administrative" costs better reflects the selling effort and enhances the comparability of our financial statements with many of our industry peers. In accordance with U.S. GAAP, the change has been reflected in the condensed consolidated statements of operations and comprehensive loss through retrospective application as follows:
10


For the three months ended March 31, 2021
(in thousands)Prior to ChangeEffect of ChangeAs Adjusted
Cost of sales$26,696 $(1,242)$25,454 
Gross profit$7,313 $1,242 $8,555 
General and administrative$8,339 $1,242 $9,581 
Total operating expenses$15,253 $1,242 $16,495 
Segment Reporting
We manage our global business operations through our operating and reportable business segments. Due to our recent merger with KushCo, we reassessed and updated our operating segments. Therefore, beginning with the fourth quarter of 2021, we determined we had following two reportable operating business segments: (1) Industrial Goods, which largely comprises KushCo's legacy operations across the United States and Canada, and (2) Consumer Goods, which largely comprises Greenlane's legacy operations across the United States, Canada, and Europe. Our reportable segments have been identified based on how our chief operating decision maker ("CODM"), which is a committee comprised of our Chief Executive Officer ("CEO") and our Chief Financial Officer ("CFO"), manage our business, make resource allocation and operating decisions, and evaluate operating performance. These changes in operating segments align with how we manage our business beginning with the fourth quarter of 2021. Segment disclosures within this Form 10-Q have been retrospectively restated to reflect the change in segments. See “Note 12—Segment Reporting.”
Revenue Recognition
Revenue under bill-and-hold arrangements was $0 and $0.2 million for the three months ended March 31, 2022 and 2021, respectively. Storage fees charged to customers for bill-and-hold arrangements are recognized as invoiced. Such fees were not significant for the three months ended March 31, 2022 and 2021.
Our liability for returns, which is included within "Accrued expenses and other current liabilities" in our condensed consolidated balance sheets, was approximately $0.9 million and $1.0 million as of March 31, 2022 and December 31, 2021. The recoverable cost of merchandise estimated to be returned by customers, which is included within "Other current assets" in our condensed consolidated balance sheets, was approximately $0.2 million as of March 31, 2022 and December 31, 2021, respectively.
For the three months ended March 31, 2022, one customer represented approximately 16% of our net sales. No single customer represented more than 10% of our net sales for the three months ended March 31, 2021. As of March 31, 2022, three  customers represented approximately 17%, 10%, and 10% of accounts receivable, respectively. As of December 31, 2021, two customers represented approximately 13% and 11% of accounts receivable, respectively.
Value Added Taxes

During the third quarter of 2020, as part of a global tax strategy review, we determined that our European subsidiaries based in the Netherlands, which we acquired on September 30, 2019, had historically collected and remitted value added tax ("VAT") payments, which related to direct-to-consumer sales to other European Union ("EU") member states, directly to the Dutch tax authorities. In connection with our subsidiaries' payment of VAT to Dutch tax authorities rather than other EU member states, we may become subject to civil or criminal enforcement actions in certain EU jurisdictions, which could result in penalties.

We performed an analysis of the VAT overpayments to the Dutch tax authorities, which we expected to be refunded to us, and VAT payable to other EU member states, including potential fines and penalties. Based on this analysis, we recorded VAT payable of approximately $1.0 million and $2.5 million relating to this matter within "Accrued expenses and other current liabilities" in our condensed consolidated balance sheet as of March 31, 2022 and December 31, 2021, respectively.

Pursuant to the purchase and sale agreement by which we acquired our European subsidiaries, the sellers are required to indemnify us against certain specified matters and losses, including any and all liabilities, claims, penalties and costs incurred or sustained by us in connection with non-compliance with tax laws in relation to activities of the sellers. The indemnity (or indemnification receivable) is limited to an amount equal to the purchase price under the purchase and sale agreement. During the three months ended March 31, 2022, we recognized a gain of approximately $1.8 million within "general and administrative expenses" in our condensed consolidated statements of operations and comprehensive loss, which represented the partial reversal of a charge previously recognized based on the difference between the VAT payable and the VAT receivable and indemnification asset, as the indemnification asset became probable of recovery based on the reduction in our previously estimated VAT liability for penalties and interest based on our voluntary disclosure to, and ongoing settlement with, the relevant tax authorities in the EU member states.

11


Management intends to pursue recovery of all additional losses from the sellers to the full extent of the indemnification provisions of the purchase and sale agreement, however, the collectability of such additional indemnification amounts may be subject to litigation and may be affected by the credit risk of indemnifying parties, and are therefore subject to significant uncertainties as to the amount and timing of recovery.

As noted above, we have voluntarily disclosed VAT owed to several relevant tax authorities in the EU member states, and believe in doing so we will reduce our liability for penalties and interest. Nonetheless, we may incur expenses in future periods related to such matters, including litigation costs and other expenses to defend our position. The outcome of such matters is inherently unpredictable and subject to significant uncertainties. Refer to "Note 7—Commitments and Contingencies" for additional discussion regarding our contingencies.
Recently Issued Accounting Guidance Not Yet Adopted
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses. The standard requires the use of an “expected loss” model on certain types of financial instruments. The standard also amends the impairment model for available-for-sale securities and requires estimated credit losses to be recorded as allowances rather than as reductions to the amortized cost of the securities. This standard is effective for fiscal years, and interim periods within those years, beginning after December 15, 2022 for filers that are eligible to be smaller reporting companies under the SEC's definition. Early adoption is permitted. We do not believe the adoption of this new guidance will have a material impact on our consolidated financial statements and disclosures.
In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides practical expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The expedients and exceptions provided by the amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. These amendments are not applicable to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope, which clarified the scope and application of the original guidance. ASU No. 2020-04 and ASU No. 2021-01 are effective as of March 12, 2020 through December 31, 2022 and may be applied to contract modifications and hedging relationships from the beginning of an interim period that includes or is subsequent to March 12, 2020. We are still evaluating the impact these standards will have on our consolidated financial statements and related disclosures.
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, as if it had originated the contracts. Prior to this ASU, an acquirer generally recognizes contract assets acquired and contract liabilities assumed that arose from contracts with customers at fair value on the acquisition date. The ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. The ASU is to be applied prospectively to business combinations occurring on or after the effective date of the amendment (or if adopted early as of an interim period, as of the beginning of the fiscal year that includes the interim period of early application). We are still assessing this standard’s impact on our consolidated financial statements.

NOTE 3. BUSINESS ACQUISITIONS
Supplemental Unaudited Pro Forma Financial Information
On March 2, 2021, we acquired substantially all the assets of Eyce LLC ("Eyce"), a designer and manufacturer of silicon pipes, bubblers, rigs, and other smoking and vaporization-related accessories and merchandise.
On August 31, 2021, we completed our previously announced merger with KushCo pursuant to the terms of the Merger Agreement dated as of March, 31, 2021.
On November 29, 2021, we acquired substantially all the assets of Organicix, LLC (d/b/a and hereinafter referred to as “DaVinci”), a leading developer and manufacturer of premium portable vaporizers.
The following table presents pro forma results for the three months ended March 31, 2022 and 2021 as if our acquisition of Eyce and DaVinci, along with the closing of the merger with KushCo, had occurred on January 1, 2021, and Eyce, DaVinci, and KushCo's results had been included in our consolidated results beginning on that date (in thousands):
12


For the three months ended March 31,
20222021
(unaudited)
Net sales$46,534 $62,793 
Cost of sales40,566 48,353 
Gross profit5,968 14,440 
Net loss$(18,749)$(18,235)

The pro forma amounts have been calculated after applying our accounting policies to the financial statements of Eyce and KushCo and adjusting the combined results of Greenlane, Eyce, DaVinci and KushCo (a) to remove Eyce and DaVinci product sales to us and to remove the cost incurred by us related to products purchased from Eyce and DaVinci prior to the acquisition, and (b) to reflect the increased amortization expense that would have been charged assuming intangible assets identified in the acquisitions of Eyce, DaVinci, and KushCo had been recorded on January 1, 2021.

The impact of the Eyce and DaVinci acquisition and the KushCo merger on the actual results reported by us in subsequent periods may differ significantly from that reflected in this pro forma information for a number of reasons, including but not limited to, non-achievement of the expected synergies from these combinations and changes in the regulatory environment. As a result, the pro forma information is not necessarily indicative of what our financial condition or results of operations would have been had the acquisitions been completed on the applicable date of this pro forma financial information. In addition, the pro forma financial information does not purport to project our future financial condition and results of operations.

NOTE 4. FAIR VALUE OF FINANCIAL INSTRUMENTS

Assets and Liabilities that are Measured at Fair Value on a Recurring Basis

The carrying amounts for certain of our financial instruments, including cash, accounts receivable, accounts payable and certain accrued expenses and other assets and liabilities, approximate fair value due to the short-term nature of these instruments.

As of March 31, 2022, we had equity securities, an interest rate swap contract and contingent consideration that are required to be measured at fair value on a recurring basis.

Our equity securities that are required to be measured at fair value on a recurring basis consist of investments in XS Financial Inc. and High Tide Inc. We have determined that our ownership does not provide us with significant influence over the operations of these entities. Accordingly, we account for our investment in these entities as equity securities, and we record changes in the fair value of these investments in "other income (expense), net" in our condensed consolidated statements of operations and comprehensive loss.

Our financial instruments measured at fair value on a recurring basis were as follows at the dates indicated:

Condensed Consolidated
Balance Sheet Caption
Fair Value at March 31, 2022
(in thousands)Level 1Level 2Level 3Total
Assets:
Equity securitiesOther assets$1,617 $ $ $1,617 
Interest rate swap contractOther assets 70  70 
Total Assets$1,617 $70 $ $1,687 
Liabilities:
Contingent consideration - currentAccrued expenses and other current liabilities$ $ $2,812 $2,812 
Contingent consideration - long-termOther long-term liabilities  554 554 
Total Liabilities$ $ $3,366 $3,366 


13


Condensed Consolidated
Balance Sheet Caption
Fair Value at December 31, 2021
(in thousands)Level 1Level 2Level 3Total
Assets:
Equity securitiesOther assets$1,919 $ $ $1,919 
Total Assets$1,919 $ $ $1,919 
Liabilities:
Interest rate swap contractOther liabilities$ $288 $ $288 
Contingent consideration - currentAccrued expenses and other current liabilities  5,641 5,641 
Contingent consideration - long-termOther long-term liabilities  1,216 1,216 
Total Liabilities$ $288 $6,857 $7,145 

The estimated fair values of our financial instruments have been determined using available market information and what we believe to be appropriate valuation methodologies. There were no transfers between Level 1 and Level 2 and no transfers to or from Level 3 of the fair value hierarchy during the three months ended March 31, 2022 and 2021, respectively.

Derivative Instrument and Hedging Activity

On July 11, 2019, we entered into an interest rate swap contract to manage our risk associated with the interest rate fluctuations on the Company's floating rate Real Estate Note described in Note 6. The counterparty to this instrument is a reputable financial institution. The interest rate swap contract is entered into for periods consistent with the related underlying exposure and does not constitute a position independent of this exposure. Our interest rate swap contract was designated as a cash flow hedge at the inception date, and is reflected at its fair value in our condensed consolidated balance sheets.
The fair value of our interest rate swap liability is determined based on the present value of expected future cash flows. Since our interest rate swap value is based on the LIBOR forward curve and credit default swap rates, which are observable at commonly quoted intervals for the full term of the swap, it is considered a Level 2 measurement. Details of the outstanding swap contract as of March 31, 2022 are as follows:
Swap MaturityNotional Value
(in thousands)
Pay Fixed RateReceive Floating RateFloating Rate
Reset Terms
October 1, 2025$7,911 2.0775 %One-Month LIBORMonthly

We performed an initial qualitative assessment of hedge effectiveness using the hypothetical derivative method in the period in which the hedging transaction was entered, as the critical terms of the hypothetical derivative and the hedging instrument were the same. On a quarterly basis, we perform a qualitative analysis for quarterly prospective and retrospective assessments of hedge effectiveness. The unrealized loss on the derivative instrument is included within "Other comprehensive income (loss)" in our condensed consolidated statement of operations and comprehensive loss. There was no measure of hedge ineffectiveness and no reclassifications from other comprehensive loss into interest expense for the three months ended March 31, 2022 and 2021.

Contingent Consideration

Each period we revalue our contingent consideration obligations associated with business acquisitions to their fair value. The estimate of the fair value of contingent consideration is determined by applying a risk-neutral framework using a Monte Carlo Simulation, which includes inputs not observable in the market, such as the risk-free rate, risk-adjusted discount rate, the volatility of the underlying financial metrics and projected financial forecast of the acquired business over the earn-out period, and therefore represents a Level 3 measurement. Significant increases or decreases in these inputs could result in a significantly lower or higher fair value measurement of the contingent consideration liability. Changes in the fair value of contingent consideration are included within "Other income (expense), net" in our condensed consolidated statements of operations and comprehensive loss.

14


A reconciliation of our liabilities that are measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3) is as follows:
(in thousands)Three months ended
March 31, 2022
Balance at December 31, 2021$6,857 
Eyce 2021 Contingent Payment settlement in Class A common stock(875)
DaVinci 2021 Contingent Payment settlement in Class A common stock(2,611)
Gain from fair value adjustments included in results of operations(5)
Balance March 31, 2022$3,366 

(in thousands)Three months ended
March 31, 2021
Balance at December 31, 2020$ 
Contingent consideration issued for Eyce acquisition1,218 
Balance at March 31, 2021$1,218 

Equity Securities Without a Readily Determinable Fair Value

Our investment in equity securities without readily determinable fair value consist of ownership interests in Airgraft Inc., Sun Grown Packaging, LLC ("Sun Grown") and Vapor Dosing Technologies, Inc. ("VIVA"). We determined that our ownership interests do not provide us with significant influence over the operations of these investments. Accordingly, we account for our investments in these entities as equity securities. Airgraft Inc., Sun Grown, and VIVA are private entities and their equity securities do not have a readily determinable fair value. We elected to measure these equity securities under the measurement alternative election at cost minus impairment, if any, with adjustments through earnings for observable price changes in orderly transactions for the identical or similar investment of the same issuer. We acquired our investments in Sun Grown and VIVA as part of our merger with KushCo, which we completed in August 2021. We did not identify any fair value adjustments related to these equity securities during the three months ended March 31, 2022 and 2021, respectively.

As of March 31, 2022 and December 31, 2021, the carrying value of our investment in equity securities without a readily determinable fair value was approximately $2.5 million, respectively, included within "Other assets" in our condensed consolidated balance sheets. The carrying value included a fair value adjustment of $1.5 million based on an observable price change recognized during the year ended December 31, 2019.

NOTE 5. LEASES
Greenlane as a Lessee
As of March 31, 2022, we had facilities financed under operating leases consisting of warehouses, offices, and retail stores, with lease term expirations between 2022 and 2027. Lease terms are generally three to seven years for warehouses, office space and retail store locations. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.
The following table provides details of our future minimum lease payments under finance and operating lease liabilities recorded in our condensed consolidated balance sheet as of March 31, 2022. The table below does not include commitments
15


that are contingent on events or other factors that are currently uncertain or unknown.
(in thousands)Operating Leases
2022$2,108 
20232,219 
20241,525 
20251,406 
2026188 
Thereafter29 
Total minimum lease payments7,475 
Less: imputed interest301 
Present value of minimum lease payments7,174 
Less: current portion2,828 
Long-term portion$4,346 
Rent expense under operating leases was approximately $0.8 million and $0.3 million for three months ended March 31, 2022 and 2021, respectively.
The following expenses related to our operating leases were included in "general and administrative" expenses within our condensed consolidated statements of operations and comprehensive loss:
For the three months ended
March 31,
(in thousands)20222021
Operating lease costs
Operating lease cost
765 250 
Variable lease cost
36 39 
Total lease cost$801 $289 
The table below presents lease-related terms and discount rates as of March 31, 2022:
March 31, 2022
Weighted average remaining lease terms 
Operating leases3.2 years
Weighted average discount rate
Operating leases2.7 %
Greenlane as a Lessor
We have five operating leases for office space leased to third-party tenants in our corporate headquarters building in Boca Raton, Florida and one sublease in California. For the three months ended March 31, 2022 and 2021, respectively, we recorded approximately $0.3 million and $0.2 million in rental income related to these operating leases, which we included within “Other income, net” in our condensed consolidated statements of operations and comprehensive loss.
The following table represents the maturity analysis of undiscounted cash flows related to lease payments, which we expect to receive from our existing operating lease agreements with tenants:
Rental Income(in thousands)
2022$575 
2023485 
202477 
202553 
Thereafter 
Total$1,190 
16


NOTE 6. DEBT
Our debt balance, excluding operating lease liabilities and finance lease liabilities, consisted of the following amounts at the dates indicated:
(in thousands)March 31, 2022December 31, 2021
Real Estate Note$7,911 $7,958 
Bridge Loan8,000 8,000 
DaVinci Promissory Note4,367 5,000 
Eyce Promissory Note1,280 1,592 
21,558 22,550 
Less unamortized debt issuance costs(323)(328)
Less current portion of debt(11,602)(11,615)
Debt, net, excluding operating leases and finance leases$9,633 $10,607 
Real Estate Note
On October 1, 2018, one of the Operating Company’s wholly-owned subsidiaries financed the purchase of a building which serves as our corporate headquarters through a real estate term note (the “Real Estate Note”) in the principal amount of $8.5 million. Principal payments plus accrued interest at a rate of one-month LIBOR plus 2.39% are due monthly, with a final payment of all remaining outstanding principal and accrued interest due in October 2025. Our obligations under the Real Estate Note are secured by a mortgage on the property. The Real Estate Note contains customary covenants and restrictions, including, without limitation, covenants that require us to comply with laws, restrictions on our ability to incur additional indebtedness, and various customary remedies for the lender following an event of default, including the acceleration of repayment of outstanding amounts under the Real Estate Note and execution upon the collateral securing obligations under the Real Estate Note. As of March 31, 2022, we were in compliance with the Real Estate Note covenants. Our Real Estate Note is subject to an interest rate swap contract, see “Note 4—Fair Value of Financial Instruments.”
One-month LIBOR is expected to be discontinued and replaced after June 2023 and the credit facility has a maturity date beyond that time. There can be no assurances as to what the alternative base rate will be once one-month LIBOR is discontinued, and we can provide no assurances whether that base rate will be more or less favorable than LIBOR. We intend to monitor the developments with respect to the phasing out of one-month LIBOR and work with our lenders to ensure that any transition away from one-month LIBOR will have minimal impact on our financial condition but can provide no assurances regarding the impact of LIBOR discontinuation.
Eyce Promissory Note
In March 2021, one of the Operating Company's wholly-owned subsidiaries financed a portion of the consideration of the acquisition of Eyce through the issuance of an unsecured promissory note (the "Eyce Promissory Note") in the principal amount of $2.5 million. Principal payments plus accrued interest at a rate of 4.5% are due quarterly through April 2023.
DaVinci Promissory Note

In November 2021, one of the Operating Company's wholly-owned subsidiaries financed the acquisition of DaVinci through the issuance of an unsecured promissory note (the "DaVinci Promissory Note") in the principal amount of $5.0 million. Principal payments plus accrued interest at a rate of 4.0% are due quarterly through October 2023.
Bridge Loan
In December 2021, we entered into a Secured Promissory Note with Aaron LoCascio, our co-founder, former Chief Executive Officer and President, and a current director of the Company, in which Mr. LoCascio provided us with a bridge loan in the principal amount of $8.0 million (the “Bridge Loan”). The Bridge Loan accrues interest at a rate of 15.0% is due monthly, and the principal amount is due in full in June 2022. We incurred $0.3 million of debt issuance costs related to the Bridge Loan, which are recorded as a direct deduction from the carrying amount of the Bridge Loan, and which will continue to be amortized over the term of the Bridge Loan through interest expense.
The Bridge Loan is secured by a continuing security interest in all of our assets and properties whether then or thereafter existing or required, including our inventory and receivables (as defined under the Universal Commercial Code) and includes negative covenants restricting our ability to incur further indebtedness and engage in certain asset dispositions until the earlier of June 30, 2022 or the Bridge Loan has been fully repaid.
NOTE 7. COMMITMENTS AND CONTINGENCIES
17


Legal Proceedings
In the ordinary course of business, we are involved in various legal proceedings involving a variety of matters. We do not believe there are any pending legal proceedings that will have a material adverse effect on our business, consolidated financial position, results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. We have not taken any reserves for litigation for the year ended December 31, 2021.
Other Commitments and Contingencies

We are potentially subject to claims related to various non-income taxes (such as sales, value added, consumption, and similar taxes) from various tax authorities, including in jurisdictions in which we already collect and remit such taxes. If the relevant taxing authorities were successfully to pursue these claims, we could be subject to significant additional tax liabilities.

See "Note 5—Leases" for details of our future minimum lease payments under operating lease liabilities. See "Note 11—Incomes Taxes" for information regarding income tax contingencies.
NOTE 8. SUPPLEMENTAL FINANCIAL STATEMENT INFORMATION
Accrued Expenses and Other Current Liabilities
The following table summarizes the composition of accrued expenses and other current liabilities as of the dates indicated:
(in thousands)March 31, 2022December 31, 2021
VAT payable (including amounts related to VAT matter described in Note 2)$3,188 $4,393 
Contingent consideration2,812 5,641 
Accrued employee compensation6,392 6,055 
Accrued professional fees2,475 1,700 
Refund liability (including accounts receivable credit balances)1,294 1,481 
Accrued construction in progress (ERP)1,086 1,061 
Sales tax payable872 1,034 
Other7,152 3,932 
$25,271 $25,297 
Customer Deposits
For certain product offerings such as child-resistant packaging, closed-system vaporization solutions and custom-branded retail products, we may receive a deposit from the customer (generally 25% - 50% of the total order cost, but the amount can vary by customer contract), when an order is placed by a customer. We typically complete orders related to customer deposits within one to six months from the date of order, depending on the complexity of the customization and the size of the order, but the order completion timeline can vary by product type and terms of sale with each customer. Changes in our customer deposits liability balance during the three months ended March 31, 2022 were as follows:
(in thousands)Customer Deposits
Balance as of December 31, 2021$7,924 
Increases due to deposits received, net of other adjustments5,213 
Revenue recognized(6,299)
Balance as of March 31, 2022$6,838 

We typically complete orders related to customer deposits within six weeks to three months from the date of order, depending on the complexity of the customization and the size of the order.

Accumulated Other Comprehensive Income (Loss)
18


The components of accumulated other comprehensive income (loss) for the periods presented were as follows:
(in thousands)Foreign Currency TranslationUnrealized Gain or (Loss) on Derivative InstrumentTotal
Balance at December 31, 2021$282 $42 $324 
Other comprehensive income (loss)88 358 446 
Less: Other comprehensive (income) loss attributable to non-controlling interest(17)(68)(85)
Balance at March 31, 2022$353 $332 $685 
(in thousands)Foreign Currency TranslationUnrealized Gain or (Loss) on Derivative InstrumentTotal
Balance at December 31, 2020$183 $(154)$29 
Other comprehensive income (loss)(155)204 49 
Less: Other comprehensive (income) loss attributable to non-controlling interest99 (130)(31)
Balance at March 31, 2021$127 $(80)$47 
Supplier Concentration
Our four largest vendors accounted for an aggregate of approximately 44.6% and 42.9% of our total net sales and 67.0% and 35.5% of our total purchases for the three months ended March 31, 2022 and 2021, respectively. We expect to maintain our relationships with these vendors.
Related Party Transactions
Nicholas Kovacevich, our Chief Executive Officer and Dallas Imbimbo, who served on our Board prior to his resignation on April 8, 2022, own capital stock of Unrivaled Brands Inc. (“Unrivaled”) and serve on the Unrivaled board of directors. Net sales to Unrivaled for the three months ended March 31, 2022 and 2021 totaled $0.2 million and $0, respectively. Total accounts receivable due from Unrivaled were $0.6 million and $0.4 million as of March 31, 2022 and December 31, 2021, respectively.
Adam Schoenfeld, co-founder and a current director of the Company, has a significant ownership interest in one of our customers, Universal Growing. Net sales to Universal Growing for the three months ended March 31, 2022 and 2021 totaled approximately $0.1 million, respectively. Total accounts receivable due from Universal Growing as of March 31, 2022 and December 31, 2021 were de minimis.
In December 2021, we entered into a Secured Promissory Note with Aaron LoCascio, our co-founder, former Chief Executive Officer and President, and a current director of the Company, with respect to the $8.0 million Bridge Loan described under Note 6 above.
NOTE 9. STOCKHOLDERS’ EQUITY
Shares of our Class A common stock have both voting interests and economic interests (i.e., the right to receive distributions or dividends, whether cash or stock, and proceeds upon dissolution, winding up or liquidation), while shares of our Class B common stock have voting interests but no economic interests. Each share of our Class A common stock and Class B common stock entitles the record holder thereof to one vote on all matters on which stockholders generally are entitled to vote, and except as otherwise required in the A&R Charter, the holders of Common Stock will vote together as a single class on all matters (or, if any holders of our preferred stock are entitled to vote together with the holders of Common Stock, as a single class with such holders of preferred stock).
Class A Common Stock Repurchase Program
In November 2019, our Board of Directors approved a stock repurchase program authorizing up to $5.0 million in repurchases of our outstanding shares of Class A common stock. Under the program, we may repurchase shares in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended. We may periodically repurchase shares in open market transactions, directly or indirectly, in block purchases and in privately negotiated transactions or otherwise. The timing, pricing, and amount of any repurchases under the share repurchase program will be determined by management at its discretion based on a variety of factors, including, but not limited to, trading volume and market price of our Class A common stock, corporate considerations, our working capital and investment requirements, general market and economic conditions, and legal requirements. The share repurchase program does not obligate us to repurchase any common stock and may be modified, discontinued, or suspended at any time. Shares of Class A common stock repurchased
19


under the program are subsequently retired. There were no share repurchases under the program during the three months ended March 31, 2022 or 2021, respectively.
Non-Controlling Interest
As discussed in “Note 1—Business Operations and Organization,” we consolidate the financial results of the Operating Company in our condensed consolidated financial statements and report a non-controlling interest related to the Common Units held by non-controlling interest holders. As of March 31, 2022, we owned 82.9% of the economic interests in the Operating Company, with the remaining 17.1% of the economic interests owned by non-controlling interest holders. The non-controlling interest in the accompanying condensed consolidated statements of operations and comprehensive loss represents the portion of the net loss attributable to the economic interest in the Operating Company held by the non-controlling holders of Common Units calculated based on the weighted average non-controlling interests’ ownership during the periods presented.
At-the-Market Equity Offering
In August 2021, we established an "at-the-market" equity offering program (the "ATM Program") that provides for the sale of shares of our Class A common stock having an aggregate offering price of up to $50 million, from time to time, through Cowen and Company, LLC ("Cowen"), as the sales agent. Net proceeds from sales of our shares of Class A common stock under the ATM Program are expected to be used for working capital and general corporate purposes.
Sales of our Class A common stock under the ATM Program may be made by means of transactions that are deemed to be an "at the market offering" as defined in Rule 415(a)(4) under the Securities Act, including sales made directly on the Nasdaq Global Market or sales made to or through a market maker or through an electronic communications network. We are under no obligation to offer and sell shares of our Class A common stock under the ATM Program.

Shares of our Class A common stock will be issued pursuant to our effective shelf registration statement on Form S-3 (File No. 333-257654), and a prospectus supplement relating to the Class A common stock that was filed with the Securities and Exchange Commission on April 18, 2022. Pursuant to Instruction I.B.6, in no event will the Company sell Class A common stock through the ATM Program with a value exceeding more than one-third of the Company’s “public float” (the market value of the Company’s Class A common stock and any other equity securities that it issues in the future that are held by non-affiliates) in any twelve-month period so long as the Company’s public float remains below $75.0 million.

On April 18, 2022, we entered into Amendment No. 1 (the “Amendment”) to the sales agreement dated August 2, 2022 with Cowen. The purpose of the Amendment is to add the limitations imposed on the ATM Program by General Instruction I.B.6 of Form S-3 (“Instruction I.B.6”) to the sales agreement. At the time of our entry into the Amendment, approximately $38.7 million in shares remained available for issuance under the ATM Program.

During the three months ended March 31, 2022, we sold 11,134,715 shares of our Class A common stock under the ATM Program, which generated gross proceeds of approximately $7.0 million and paid fees to the sales agent of approximately $0.2 million. Since the launch of the ATM program in August 2021 and through March 31, 2022, we sold 13,535,970 shares of our Class A common stock under the ATM Program, which generated gross proceeds of approximately $10.4 million and paid fees to the sales agent of approximately $0.3 million.
Common Stock and Warrant Offering

On August 9, 2021, we entered into securities purchase agreements with certain accredited investors, pursuant to which we agreed to issue and sell an aggregate of 4,200,000 shares of our Class A common stock, pre-funded warrants to purchase up to 5,926,583 shares of our Class A common stock (the “Pre-Funded Warrants”) and warrants to purchase up to 6,075,950 shares of our Class A common stock (the “Standard Warrants” and, together with the Pre-Funded Warrants, the “Warrants”), in a registered direct offering (the “Offering”). The shares of Class A common stock and Warrants were sold in Units (the “Units”), with each unit consisting of one share of Class A common stock or a Pre-Funded Warrant and a Standard Warrant to purchase 0.6 of a share of our Class A common stock. The Units were offered pursuant to our existing shelf registration statement on Form S-3. Subject to certain ownership limitations, the Standard Warrants were immediately exercisable at an exercise price equal to $3.55 per share of Class A common stock. The Standard Warrants are exercisable for five years from the date of issuance. Each Pre-Funded Warrant was exercisable with no expiration date for one Share of Class A common stock at an exercise price of $0.01. The Offering generated gross proceeds of approximately $31.9 million and net proceeds to the Company of approximately $29.9 million. All Pre-Funded Warrants were exercised in August and September 2021, based upon which we issued an additional 5,926,583 shares of our Class A common stock, for net proceeds of approximately $0.1 million.
Class C Common Stock Conversion

On August 31, 2021, we completed our merger with KushCo. Pursuant to the Merger Agreement, immediately prior to the consummation of the Mergers, holders of Class C common stock, $0.0001 par value per share, received one-third of one share
20


of Class B common stock, for each share of Class C common stock held, and Greenlane adopted the A&R Charter which eliminated Class C common stock as a class of Greenlane’s capital stock.
Net Loss Per Share
Basic net loss per share of Class A common stock is computed by dividing net loss attributable to Greenlane by the weighted-average number of shares of Class A common stock outstanding during the period. Diluted net loss per share of Class A common stock is computed by dividing net loss attributable to Greenlane by the weighted-average number of shares of Class A common stock outstanding adjusted to give effect to potentially dilutive elements.
A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per share of our Class A common stock is as follows (in thousands, except per share amounts):
Three months ended March 31,
(in thousands, except per share data)20222021
Numerator:
Net loss$(18,749)$(7,714)
Less: Net loss attributable to non-controlling interests(3,417)(3,458)
Net loss attributable to Class A common stockholders$(15,332)$(4,256)
Denominator:
Weighted average shares of Class A common stock outstanding90,170 15,263 
Net loss per share of Class A common stock - basic and diluted$(0.17)$(0.28)
For the three months ended March 31, 2022 and 2021, shares of Class B common stock, shares of Class C common stock and stock options and warrants to purchase Class A common stock were excluded from the weighted-average in the computation of diluted net loss per share of Class A common stock because the effect would have been anti-dilutive.
Shares of our Class B common stock and Class C common stock do not share in our earnings or losses and are therefore not participating securities. As such, separate calculations of basic and diluted net loss per share for each of our Class B common stock and Class C common stock under the two-class method have not been presented.
NOTE 10. COMPENSATION PLANS
Amended and Restated 2019 Equity Incentive Plan
In April 2019, we adopted the 2019 Equity Incentive Plan (the “2019 Plan”). We previously registered 5,000,000 shares of Class A common stock that are or may become issuable under the 2019 Plan as stock options and other equity-based awards to employees, directors and executive officers. In August 2021, we adopted, and our shareholders approved, the Amended and Restated 2019 Equity Incentive Plan (the "Amended 2019 Plan"), which amends and restates the 2019 Plan in its entirety. The Amended 2019 Plan, among other things, increases the number of shares of Class A common stock available for issuance under the 2019 Plan by 2,860,367.
The Amended 2019 Plan provides eligible participants with compensation opportunities in the form of cash and equity incentive awards. The 2019 Plan is designed to enhance our ability to attract, retain and motivate our employees, directors, and executive officers, and incentivizes them to increase our long-term growth and equity value in alignment with the interests of our stockholders.
KushCo Equity Plan

On August 31, 2021, we completed our previously announced merger with KushCo pursuant to the Merger Agreement dated as of March, 31, 2021. In connection with the completion of our merger with KushCo, we assumed the sponsorship of the KushCo Equity Plan. We do not intend to make future grants under the KushCo Equity Plan.
Rule 10b5-1 Trading Plans

During the three months ended March 31, 2022, Section 16 officer Adam Schoenfeld had an equity trading plan in place in accordance with Rule 10b5-1(c)(1) under the Exchange Act. An equity trading plan is a written document that preestablishes the amounts, prices and dates (or formula for determining the amounts, prices and dates) of future purchases or sales of our Class A common stock, including shares acquired under our equity plans.
Equity-Based Compensation Expense
21


Equity-based compensation expense is included within "salaries, benefits and payroll taxes" in our condensed consolidated statements of operations and comprehensive loss. We recognized equity-based compensation expense as follows:
For the three months ended
March 31,
(in thousands)20222021
Stock options - Class A common stock$674 $320 
Restricted shares - Class A common stock188 110 
Restricted stock units (RSUs) - Class A common stock11 24 
Common units of the Operating Company 76 
Total equity-based compensation expense$873 $530 
Total remaining unrecognized compensation expense as of March 31, 2022 was as follows:
Remaining Unrecognized Compensation Expense
March 31, 2022
Weighted Average Period over which Remaining Unrecognized Compensation Expense is Expected to be Recognized
(in thousands)(in years)
Stock options - Class A common stock$1,306 1.3
Restricted shares - Class A common stock864 1.8
Restricted stock units (RSUs) - Class A common stock25 2.9
Total remaining unrecognized compensation expense$2,195 
NOTE 11. INCOME TAXES
As a result of the IPO and the related transactions completed in April 2019, we own a portion of the Common Units of the Operating Company, which is treated as a partnership for U.S. federal and most applicable state and local income tax purposes. As a partnership, the Operating Company is generally not subject to U.S. federal and certain state and local income taxes. Any taxable income or loss generated by the Operating Company is passed through to and included in the taxable income or loss of its members, including Greenlane, on a pro-rata basis, in accordance with the terms of the Operating Agreement. The Operating Company is also subject to taxes in foreign jurisdictions. We are a corporation subject to U.S. federal income taxes, in addition to state and local income taxes, based on our share of the Operating Company’s pass-through taxable income.
The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), which was enacted on March 27, 2020, made tax law changes to provide financial relief to companies as a result of the business impacts of COVID-19. Key income tax provisions of the CARES Act include changes in net operating loss carryback and carryforward rules, acceleration of alternative minimum tax credit recovery, increase in the net interest expense deduction limit and charitable contribution limit, and immediate write-off of qualified improvement property. The changes are not expected to have a significant impact on us. The Consolidation Appropriations Act of 2021, enacted on December 27, 2020, extended and enhanced COVID relief provisions of the CARES Act. The Company has evaluated the impact of the Consolidated Appropriation Act and determined that its impact is not material to the Company’s financial statements.
As of March 31, 2022 and December 31, 2021, management performed an assessment of the realizability of our deferred tax assets based upon which management determined that it is not more likely than not that the results of operations will generate sufficient taxable income to realize portions of the net operating loss benefits. Consequently, we established a full valuation allowance against our deferred tax assets, and reflected a carrying balance of $0 as of March 31, 2022 and December 31, 2021, respectively. In the event that management determines that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, an adjustment to the valuation allowance will be made, which would reduce the provision for income taxes. The provision for and benefit from income taxes for the three months ended March 31, 2022 and 2021, respectively, relates to taxes in foreign jurisdictions, including Canada and the Netherlands.
For the three months ended March 31, 2022 and 2021, the effective tax rate differed from the U.S. federal statutory tax rate of 21% primarily due to the Operating Company's pass-through structure for U.S. income tax purposes, the relative mix in earnings and losses in the U.S. versus foreign tax jurisdictions, and the valuation allowance against the deferred tax asset.
We do not record U.S. income taxes on the undistributed earnings of our foreign subsidiaries, except for the Canadian subsidiary, based upon our intention to permanently reinvest undistributed earnings to ensure sufficient working capital and further expansion of existing operations outside the United States. In the event we are required to repatriate funds from outside of the United States, such repatriation would be subject to local laws, customs, and tax consequences.

Uncertain Tax Positions
22



For the three months ended March 31, 2022 and 2021, we did not have any unrecognized tax benefits as a result of tax positions taken during a prior period or during the current period. No interest or penalties have been recorded as a result of tax uncertainties. The Company is subject to audit examination for federal and state purposes for the years 2018 – 2020.

Tax Receivable Agreement (TRA)
We entered into the TRA with the Operating Company and each of the members (other than Greenlane Holdings, Inc.) that provides for the payment by the Operating Company to the members of 85% of the amount of tax benefits, if any, that we may actually realize (or in some circumstances are deemed to realize) as a result of (i) increases in tax basis resulting from any future redemptions of Common Units as described in “Note 1—Business Operations and Organization” and (ii) certain other tax benefits attributable to payments made under the TRA.
The annual tax benefits are computed by calculating the income taxes due, including such tax benefits, and the income taxes due without such benefits. The Operating Company expects to benefit from the remaining 15% of any tax benefits that it may actually realize. The TRA payments are not conditioned upon any continued ownership interest in the Operating Company. The rights of each noncontrolling interest holder under the TRA are assignable to transferees of its interest in the Operating Company. The timing and amount of aggregate payments due under the TRA may vary based on a number of factors, including the amount and timing of the taxable income the Operating Company generates each year and the applicable tax rate.

As noted above, we evaluated the realizability of the deferred tax assets resulting from the IPO and the related transactions completed in April 2019 and established a full valuation allowance against those benefits. As a result, we determined that the amount or timing of payments to noncontrolling interest holders under the TRA are no longer probable or reasonably estimable. Based on this assessment, our TRA liability was $0 as of March 31, 2022 and December 31, 2021.

If utilization of the deferred tax assets subject to the TRA becomes more likely than not in the future, we will record a liability related to the TRA, which would be recognized as expense within our condensed consolidated statements of operations and comprehensive (loss) income.
During the three months ended March 31, 2022 and 2021, we did not make any payments, inclusive of interest, to members of the Operating Company pursuant to the TRA.
NOTE 12. SEGMENT REPORTING
We define our segments as those operations whose results are regularly reviewed by our CODM to analyze performance and allocate resources. Therefore, segment information is prepared on the same basis that management reviews financial information for operational decision-making purposes. Our CODM is a committee comprised of our CEO and our CFO.
Following the completion of the KushCo merger in late August 2021, we reassessed our operating segments based on our new organizational structure. Based on this assessment, we determined we had the following two operating segments as of March 31, 2022 and December 31, 2021, which are the same as our reportable segments: (1) Consumer Goods, which largely comprises Greenlane's legacy operations across the United States, Canada, and Europe, and (2) Industrial Goods, which largely comprises KushCo's legacy operations across the United States and Canada. These changes in operating segments align with how we manage our business beginning with the fourth quarter of 2021. The segment disclosures below have been retrospectively restated to reflect the change in segments.
The Consumer Goods segment focuses on serving consumers across wholesale, retail and e-commerce operations—through both our proprietary Greenlane Brands, including Eyce, DaVinci, VIBES, Marley Natural, Keith Haring, and Higher Standards, as well as lifestyle products and accessories from leading brands, like PAX, Storz and Bickel, Grenco Science, and many more. The Consumer Goods segment forms a central part of our growth strategy, especially as it relates to scaling our own portfolio of higher-margin Greenlane Brands.
The Industrial Goods segment focuses on serving the premier brands, operators, and retailers through our wholesale operations by providing ancillary products essential to their growth, such as customizable packaging and supply products and vaporization solutions offering which includes CCELL branded products.
Our CODM allocates resources to and assesses the performance of our two operating segments based on the operating segments' net sales and gross profit. The following table sets forth information by reportable segment for the three months ended March 31, 2022 and 2021, respectively. There were no material intersegment sales during the three months ended March 31, 2022 and 2021, respectively.
23